Trial intelligence / Profile preview

Hepatitis B therapeutic vaccine study in asymptomatic carriers

IRCT201202259124N1Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
Oct 2007
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of Hepatitis B vaccine, sponsored by Golestan University of Medical Sciences. Started Oct 2007; status: completed.

02

Drugs

Hepatitis B vaccine

Beyond the preview

Go deeper on IRCT201202259124N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201202259124N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call